{
  "metadata": {
    "title": "Chiral Cr(III)-<ce:italic>salen</ce:italic> complex embedded over sulfonic acid functionalized mesoporous SBA-15 material as an efficient catalyst for the asymmetric Henry reaction",
    "authors": "; ; ",
    "journal": "Molecular Catalysis",
    "date": "2019-10-31",
    "doi": "10.1016/j.mcat.2019.110489",
    "abstract": "",
    "uri": "https://api.elsevier.com/content/article/pii/S2468823119303244",
    "pii": "S2468823119303244"
  },
  "fulltext": {
    "full-text-retrieval-response": {
      "scopus-eid": "2-s2.0-85067915877",
      "originalText": "serial JL 315758 291210 291744 291790 291809 31 Molecular Catalysis MOLECULARCATALYSIS 2019-06-27 2019-06-27 2019-06-27 2019-06-27 2019-08-06T07:55:47 1-s2.0-S2468823119303244 S2468-8231(19)30324-4 S2468823119303244 10.1016/j.mcat.2019.110489 S300 S300.1 FULL-TEXT 1-s2.0-S2468823119X00115 2020-06-15T23:47:11.021994Z 0 0 20191001 20191031 2019 2019-06-27T19:44:57.686882Z absattachment articleinfo articlenumber articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pii piinorm pubdateend pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table e-component body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast footnotes grantsponsor grantsponsorid highlightsabst orcid primabst ref specialabst 2468-8231 24688231 true 475 475 C Volume 475 21 110489 110489 110489 201910 October 2019 2019-10-01 2019-10-31 2019 Regular Papers article fla © 2019 Elsevier B.V. All rights reserved. CHIRALCRIIISALENCOMPLEXEMBEDDEDOVERSULFONICACIDFUNCTIONALIZEDMESOPOROUSSBA15MATERIALEFFICIENTCATALYSTFORASYMMETRICHENRYREACTION ISLAM M 1 Introduction 2 Experimental section 2.1 Synthesis of the chiral Cr(III) containing salen-like complex (E) 2.1.1 Preparation of 3-tert-butyl-5-chloromethyl-2-hydroxybenzaldehyde (B) 2.1.2 Preparation of the complex C 2.1.3 Synthetic procedure for the chiral Schiff base ligand D 2.1.4 Preparation of chiral complex E 2.2 Preparation of -SO3H functionalized SBA-15 (SAFSB) 2.3 Synthesis of the heterogeneous Cr(III)@SAFSB catalyst 2.4 General procedure for asymmetric nitro aldol reaction 2.5 Synthesis of (R)-(-)-Isoproterenol 2.6 General procedure for recycling experiment 3 Results and discussion 3.1 Characterization of Cr(III)@SAFSB catalyst 3.1.1 Powder X-ray diffraction pattern (PXRD) 3.1.2 UHR-TEM 3.1.3 N2 adsorption/desorption isotherm 3.1.4 X-ray photoelectron spectroscopy (XPS) 3.1.5 FT-IR spectral analysis 3.1.6 Elemental analysis 3.2 Enantioselective Henry Reaction 3.3 Reusability of chiral Cr(III)@SAFSB catalyst 3.4 Leaching tests 4 Conclusion Acknowledgments Appendix A Supplementary data References PALOMO 2007 2561 2574 C MENAPARA 2016 161 166 T BANDINI 2007 616 618 M TROST 2002 2621 2623 B MA 2017 526 533 Z LANG 2012 1620 1624 K SHARMA 2010 61 66 K ELASAAD 2017 76 81 B WANG 2009 589 592 F MASE 2006 4966 4967 N JALAL 2013 4823 4830 S SASAI 1992 4418 4420 H AITKEN 2013 2627 2648 L LIU 2018 144 172 X KURESHY 2011 1529 1535 R JAMMI 2009 314 320 S DAS 2014 411 418 A ALVAREZCASAO 2011 220 245 Y SEKIKAWA 2016 646 649 T BULUT 2008 7373 7375 A SHIBASAKI 1997 1236 1256 M PARK 2008 16484 16485 J DIMROTH 2015 29108 29113 J PANDYA 2007 3842 3846 S BHATT 2006 110 117 A KOWALCZYK 2009 753 756 R ZULAUF 2009 2242 2245 A OUYANG 2014 16454 16457 G ZHAO 1998 548 552 D DAS 2010 1326 1333 S VERMA 2011 1897 1902 S CHEN 2011 2920 2930 S PONNURU 2018 247 260 K ISLAM 2016 109315 109321 M OSTOVAR 2018 77 S LIGUORI 2017 3245 3258 F HALDER 2016 97599 97605 M HALDER 2018 11896 11904 M REGAMEY 2008 837 843 N VILSKERSTS 2009 281 R SASIDHARANA 2013 1 6 M ADAM 2012 1048 1058 F LI 2014 42376 42382 X NAKAJIMA 2012 1296 K DAS 2013 97 105 A BLAY 2010 578 581 G PUGIN 2010 B HETEROGENIZEDHOMOGENEOUSCATALYSTSFORFINECHEMICALSPRODUCTION ISLAMX2019X110489 ISLAMX2019X110489XM 2021-06-27T00:00:00.000Z 2021-06-27T00:00:00.000Z http://creativecommons.org/licenses/by-nc-nd/4.0/ © 2019 Elsevier B.V. All rights reserved. 2019-06-21T17:07:11.766Z http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/eoas SERB Science and Engineering Research Board http://data.elsevier.com/vocabulary/SciValFunders/501100001843 http://sws.geonames.org/1269750 item S2468-8231(19)30324-4 S2468823119303244 1-s2.0-S2468823119303244 10.1016/j.mcat.2019.110489 315758 2020-06-15T23:47:11.021994Z 2019-10-01 2019-10-31 1-s2.0-S2468823119303244-main.pdf https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/MAIN/application/pdf/a6380bafe1302b045bbcc1f601a28449/main.pdf main.pdf pdf true 4517610 MAIN 9 1-s2.0-S2468823119303244-main_1.png https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/PREVIEW/image/png/5b451d0e1c92e9ce02c225416592a78e/main_1.png main_1.png png 53589 849 656 IMAGE-WEB-PDF 1 1-s2.0-S2468823119303244-fx1.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/fx1/THUMBNAIL/image/gif/95c112750cb492cc439ae4b9193ed90e/fx1.sml fx1 fx1.sml sml 2903 40 219 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-fx2.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/fx2/THUMBNAIL/image/gif/bec99713b3ab0dd4989996b5a38af36a/fx2.sml fx2 fx2.sml sml 3053 32 219 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-ga1.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/ga1/THUMBNAIL/image/gif/454ea9b37c4ef159fac78b5840b5f05e/ga1.sml ga1 true ga1.sml sml 9588 111 219 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-gr1.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr1/THUMBNAIL/image/gif/27b6cad48e8df3b35ac8406f39c6d9c2/gr1.sml gr1 gr1.sml sml 3931 164 144 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-gr2.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr2/THUMBNAIL/image/gif/967d05ba5e305e3fe4ed7b3d4ac94daa/gr2.sml gr2 gr2.sml sml 15772 163 164 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-gr3.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr3/THUMBNAIL/image/gif/00914dfb902a2d0d60d0e167cb735da3/gr3.sml gr3 gr3.sml sml 5170 163 99 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-gr4.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr4/THUMBNAIL/image/gif/318b2144d6d025c716101a648533fd3e/gr4.sml gr4 gr4.sml sml 7461 164 164 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-gr5.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr5/THUMBNAIL/image/gif/6dfa844e3c69c9da2e83c4db590b80ae/gr5.sml gr5 gr5.sml sml 8504 103 219 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-sc1.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/sc1/THUMBNAIL/image/gif/93556c4c8533cb03a5a1aa32b2ed3c92/sc1.sml sc1 sc1.sml sml 3335 52 219 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-sc2.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/sc2/THUMBNAIL/image/gif/dd71d55280d27b7112610b738ce6bef7/sc2.sml sc2 sc2.sml sml 7333 164 139 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-sc3.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/sc3/THUMBNAIL/image/gif/7340e4e98156f824bef7e105ac088f48/sc3.sml sc3 sc3.sml sml 5907 116 219 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-sc4.sml https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/sc4/THUMBNAIL/image/gif/23e07315c460ece025d194e96bbdd9bd/sc4.sml sc4 sc4.sml sml 8315 147 219 IMAGE-THUMBNAIL 1-s2.0-S2468823119303244-fx1.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/fx1/DOWNSAMPLED/image/jpeg/e16d1b8e64854457b5ade60dfd32d0da/fx1.jpg fx1 fx1.jpg jpg 4882 47 257 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-fx2.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/fx2/DOWNSAMPLED/image/jpeg/c2416b82c7d96856ad1d13ecf08ed685/fx2.jpg fx2 fx2.jpg jpg 5189 37 247 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-ga1.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/ga1/DOWNSAMPLED/image/jpeg/98c462fe23b1e468371305923569490e/ga1.jpg ga1 true ga1.jpg jpg 26017 200 396 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-gr1.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr1/DOWNSAMPLED/image/jpeg/782613a24991346b5b1d81de16d6af45/gr1.jpg gr1 gr1.jpg jpg 20528 385 339 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-gr2.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr2/DOWNSAMPLED/image/jpeg/aaf43b020a68c33fdaba2754727d027f/gr2.jpg gr2 gr2.jpg jpg 104221 563 565 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-gr3.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr3/DOWNSAMPLED/image/jpeg/54bdf8d1cfc100b6b34c3f98f438f90d/gr3.jpg gr3 gr3.jpg jpg 43591 557 339 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-gr4.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr4/DOWNSAMPLED/image/jpeg/6d69f8e1e362f8e94ede8a4beddf073d/gr4.jpg gr4 gr4.jpg jpg 61705 564 565 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-gr5.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/gr5/DOWNSAMPLED/image/jpeg/4ca05cd0fdd37547c2faa392087969ea/gr5.jpg gr5 gr5.jpg jpg 17203 160 339 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-sc1.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/sc1/DOWNSAMPLED/image/jpeg/fe917a6ccaab785eba3f3ebd94cc6bd1/sc1.jpg sc1 sc1.jpg jpg 9564 81 339 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-sc2.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/sc2/DOWNSAMPLED/image/jpeg/f18926d5f05543e7d752e681e0f99f10/sc2.jpg sc2 sc2.jpg jpg 93917 667 565 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-sc3.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/sc3/DOWNSAMPLED/image/jpeg/a751bc2694fd660e6db3b2eb1e57c604/sc3.jpg sc3 sc3.jpg jpg 25181 259 489 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-sc4.jpg https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/sc4/DOWNSAMPLED/image/jpeg/9a836e1f781ba87f25bab4e472ae2f40/sc4.jpg sc4 sc4.jpg jpg 39640 328 489 IMAGE-DOWNSAMPLED 1-s2.0-S2468823119303244-mmc1.doc https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S2468823119303244/mmc1/MAIN/application/msword/2a2355e78c366a2b9a37e25fc43d8679/mmc1.doc mmc1 mmc1.doc doc 1239040 APPLICATION 1-s2.0-S2468823119303244-am.pdf am am.pdf pdf 794707 AAM-PDF https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/egi:109BDDKSZZR/MAIN/application/pdf/00e009021e25e1dc7a06b9ab2f1be718/am.pdf MCAT 110489 110489 S2468-8231(19)30324-4 10.1016/j.mcat.2019.110489 Elsevier B.V. Scheme 1 Schematic presentation of asymmetric Henry reaction. Scheme 1 Scheme 2 Schematic diagram for the synthesis of Cr(III)@SAFSB. Scheme 2 Scheme 3 Most plausible transition state of asymmetric Henry reaction over Cr(III)@SAFSB. Scheme 3 Scheme 4 Reaction pathway for the synthesis of drug R-isoproterenol. Scheme 4 Fig. 1 Small angle powder XRD pattern of (a) SAFSB and (b) Cr(III)@SAFSB. Fig. 1 Fig. 2 UHR-TEM images of SAFSB (a,b) and Cr(III)@SAFSB (c,d). Respective FFT patterns are shown in the insets of Figs. 2b and 2c. Fig. 2 Fig. 3 (A) Nitrogen adsorption-desorption isotherm of parent SBA-15 (a) Cr(III)@SAFSB (b) materials, where adsorption and desorption isotherms are marked by filled and empty circles, respectively. (B) The pore size distribution plots of pure SBA-15 (a) and Cr(III)@SAFSB (b) are shown. Fig. 3 Fig. 4 Narrow range XPS spectra of Cr 2p (a), S 2p (b), C 1s (c) and Si 2p (d) elements. Fig. 4 Fig. 5 Recyclability of Cr(III)@SAFSB for the asymmetric Henry reaction. Fig. 5 Table 1 Assymetric Henry reaction catalyzed by Cr(III)@SAFSB under different conditions a . Table 1 Entry Cat. (mg) Solvent Base T (ºC) t (h) Yield b (%) ee c 1 – – – 4 48 nd nd 2 15 EtOH Et3N 4 16 74 65 3 15 Et2O Et3N 4 16 40 23 4 15 THF Et3N 4 16 66 76 5 15 Toluene Et3N 4 16 70 39 6 15 DCM Et3N 4 16 87 88 7 15 DCM – 4 16 55 78 8 15 DCM DIPEA 4 16 79 38 9 15 DCM Cs2CO3 4 16 64 <5 10 15 DCM DBU 4 16 75 <5 11 15 DCM Et3N −10 16 80 90 12 15 DCM Et3N RT 16 69 35 13 10 DCM Et3N 4 16 70 77 14 20 DCM Et3N 4 16 89 73 15 d 15 DCM Et3N 4 16 78 86 16 e 15 DCM Et3N 4 16 10 – 17 f 15 DCM Et3N 4 16 12 – 18 g 15 DCM Et3N 4 16 39 83 a Reaction Condition: 1a (1 mmol), CH3NO2 (8 mmol), Base (1 mmol), Cr(III)@SAFSB, Solvent (2 mL). b Isolated yield. c Determined by HPLC using Chiralcel OD-H column. d 0.5 mmol Et3N is used. e SBA-15 is used as catalyst. f Organo modified SBA-15 (SAFSB) is used as catalyst. g 1 mmol CH3NO2 is used. Table 2 Substrate scope of Cr(III)@SAFSB catalyzed asymmetric Henry reaction a . Table 2 Entry (R) Product Yield c (%) ee d (%) TON e 1 4-MeC6H4 (1a) 2a 87 88 349 2 Ph (1b) 2b 90 91 362 3 3-ClC6H4 (1c) 2c 85 84 341 4 4-ClC6H4 (1d) 2d 86 86 345 5 4-NO2C6H4 (1e) 2e 89 91 357 6 4-MeOC6H4 (1f) 2f 85 86 341 7 3,4-diMeOC6H3 (1 g) 2 g 88 89 353 8 2-thiophenyl (1 h) 2h 82 86 329 9 2-furyl (1i) 2i 80 83 321 10 b CH3(CH2)4CH2 (1 j) 2j 78 77 313 a Conditions: aldehyde (1.0 mmol), CH3NO2 (8.0 mmol), Cr(III)@SAFSB (15 mg, 2.49 × 10−6 mol or 0.249 mol% of Cr), Et3N (1.0 mmol), DCM, 4 °C temp., 16 h. b 20 h is required. c Isolated yields. d enantiomeric excesses were determined by HPLC analysis. e TON: moles of substrate converted/mole of active site. Table 3 Comparative study for asymmetric Henry reactions over homogeneous Cr(III)-salen complex (E) and Cr(III)@SAFSB a . Table 3 Catalyst t (h) Yield b (%) ee c (%) Homogeneous Cr(III)-salen complex (E) 14 82 92 Heterogeneous Cr(III)@SAFSB 16 90 91 a Conditions: PhCHO (1.0 mmol), CH3NO2 (8.0 mmol), Cr(III) catalyst (0.249 mol% of Cr), Et3N (1.0 mmol), DCM, 4 °C. b Isolated yields. c Enantiomeric excesses were determined by HPLC analysis (Figure S3-S4, ESI). Chiral Cr(III)-salen complex embedded over sulfonic acid functionalized mesoporous SBA-15 material as an efficient catalyst for the asymmetric Henry reaction Md. Mominul Islam a Piyali Bhanja b Mita Halder c 1 Anjan Das a 1 Asim Bhaumik b ⁎ Sk. Manirul Islam a ⁎ a Department of Chemistry, University of Kalyani, Kalyani, Nadia, 741235, WB, India Department of Chemistry University of Kalyani Nadia Kalyani WB 741235 India Department of Chemistry, University of Kalyani, Kalyani, Nadia, 741235, WB, India, Tel.: +91 33 2582 8750; Fax: +91 33 2582 8282 b School of Materials Sciences, Indian Association for the Cultivation of Science, Jadavpur 700 032, India School of Materials Sciences Indian Association for the Cultivation of Science Jadavpur 700 032 India School of Materials Sciences, Indian Association for the Cultivation of Science, Jadavpur 700 032, India c Department of Chemistry, University of Calcutta, 92 APC Road, Kolkata 700 009, India Department of Chemistry University of Calcutta 92 APC Road Kolkata 700 009 India Department of Chemistry, University of Calcutta, 92 APC Road, Kolkata 700 009, India ⁎ Corresponding authors. 1 These authors contributed equally to this manuscript. Graphical abstract A new heterogeneous chiral catalyst Cr(III)@SAFSB has synthesized for asymmetric Henry reaction (ee up to 91%, yield up to 90%) of aromatic and aliphatic aldehydes with nitromethane. Enantiomerically pure drug (R)-(-)-isoproterenol has been synthesized by using this strategy in high yield. Designing novel catalytic system for efficient synthesis of enantiomerically pure β-hydroxy nitroalkanes is a challenging area of research. Herein, we have designed a chiral heterogeneous catalyst through the successful loading of chiral Cr(III)-salen complex over sulfonic acid functionalized SBA-15 material. The catalyst has been thoroughly characterized by powder XRD, N2 adsorption/desorption, XPS, HR-TEM, CHN, AAS analyses and FT-IR spectroscopy. The reactivity of the catalyst has been examined in the enantioselective Henry reaction, where different substituted aromatic, heteroaromatic as well as aliphatic aldehydes produced corresponding β-hydroxy nitroalkanes with excellent product yields (up to 90%) and enantioselectivities (up to 91%). Moreover, this protocol has also been employed as the key-step to prepare enantiomerically pure drug (R)-(-)-isoproterenol from 3,4-dimethoxybenzaldehyde. Keywords Asymmetric synthesis Nitroaldol reaction Heterogeneous catalysis Cr(III)-salen (R)-isopoterenol 1 Introduction Asymmetric nitroaldol reaction between aldehydes and nitroalkanes (Scheme 1 ) is one of the most important and convenient carbon-carbon bond formation strategy for the production of enantiomerically pure β-hydroxy nitroalkanes [1,2]. It has drawn great attention among the researchers due to its wide range of synthetic utilities, especially in medicinally effectual compounds, chiral ligands, bioactive reagents, etc. [3–6]. Moreover, chemical flexibility of the nitro group [7,8] could make the resulting enantiopure β-hydroxy nitroalkanes highly potent, chemically active and privileged as well as precious structural motifs for the preparation of more useful compounds [9–11]. Hence, design and synthesis of efficient, novel and reactive chiral catalyst for the preparation of enantiomerically pure β-hydroxy nitroalkanes is very challenging. Sasai et al. first reported the chiral lanthanum alkoxide complex as an effective catalyst for this reaction [12]. Thereafter, this area of research has been enriched over the years by successful execution of an arsenal of chiral catalysts [13,14]. In this context, a significant number of catalysts including heterogeneous chiral catalysts [15–17] as well as organocatalysts [18,19] have been developed and employed to achieve the goal. Amongst them designing suitable metal-complex based catalysts of Cu [17], Zn [20], Zr [21], Co [22,23] and rare earth metals [24,25], are very important in the field of materials chemistry. Majority of these catalytic systems involve high catalyst loading as well as use of molecular sieves and dry solvents to obtain high product yields. To surmount all these obstacles together with high expenditure for the catalyst synthesis and to improve the recycling efficiency of the catalyst some advanced modifications are highly desirable. Notably, the multi-faceted functions are less developed till date. In this context, chromium-based transition metal catalysts have witnessed considerable attention among the researchers. However, reports on chiral Cr(III)-salen complex catalysed asymmetric nitro-aldol reaction are in severe dearth in recent decades. Although, Kowalczyk et al. [26] Zulauf et al. [27] Ouyang et al. [28] have reported homogeneous Cr(III)-salen catalytic systems for asymmetric Henry reaction, efficient heterogeneous chiral catalysts bearing Cr(III) as the active metal centre for this reaction is still very demanding specially in the context of sustainability of the processes. Porous nanomaterials and their functionalized analogues [29–36] possess large specific surface area, easily tunable and consistent pores of nanoscale dimensions, and good thermal stability. They are intensively studied as catalyst and solid support over the years. Post synthesis functionalization of the surfaces of mesoporous silica materials are particularly found wide scale utility in designing suitable catalysts for the production of organic fine chemicals. Accordingly, we have reported few key asymmetric transformations catalysed by surface modified mesoporous SBA-15 grafted with chiral metal-salen complexes [37,38]. To establish the strategy to construct new asymmetric CC bond herein, we report the synthesis of a chiral Cr(III)-salen containing sulfonic acid functionalized SBA-15 silica material, Cr(III)@SAFSB (Scheme 2 ), which catalyses efficiently for the asymmetric Henry reaction. Furthermore, using this technique, we finally end up in synthesizing medicinally persuasive drug (R)-isoproterenol as a spin off, which is widely used for the treatment of asthma, bronchitis, heart blockage and emphysema [39–41] etc. It is highly important to note that (R)-form of this drug is around 90 times more powerful than the (S)-form [39]. 2 Experimental section 2.1 Synthesis of the chiral Cr(III) containing salen-like complex (E) Homogeneous chiral Schiff base ligand (E) was prepared (Scheme 2) from 3- t butyl-2-hydroxy-benzaldehyde (A), following our previously reported literature [37] and the steps are stated below. 2.1.1 Preparation of 3-tert-butyl-5-chloromethyl-2-hydroxybenzaldehyde (B) In a typical synthesis 15 mmol of 3-tert-butyl-2-hydroxy benzaldehyde (A) and 33 mmol of paraformaldehyde were added to a pre-cooled (5–10 ℃) medium of 11 ml concentrated HCl. Then this reaction mixture was stirred at 313 K for 72 h. Thereafter, the resulting crude mixture was repetitively extracted using diethyl ether, followed by washing with saturated aqueous solution of NaHCO3 and brine. Then organic part was dried using anhydrous Na2SO4 and evaporated to acquire B as a yellowish crystalline solid (94% yield). The 1H NMR data of the product was in agreement with those reported earlier. 2.1.2 Preparation of the complex C In a typical synthesis a dry benzene solution of triethylamine (0.5 mmol, 5 mL) was added drop wise to the stirred solution of compound B (0.5 mmol, 5 mL) in dry benzene and the final mixture was then refluxed for 36 h. After completion of the reaction the mixture was cooled to room temperature and solvent was evaporated to furnish quaternary aldehyde C (94% yield). The spectroscopic data of the product was in accordance with the reported literature. 2.1.3 Synthetic procedure for the chiral Schiff base ligand D Then an ethanolic (absolute) solution of (1S, 2S)-(+)-1,2-diaminocyclohexane (1 equivalent) was added drop wise to the ethanolic (absolute) solution of complex C (2 eqvt.) and the final mixture was refluxed for 9 h (monitored on TLC). Then after partial evaporation of the solution, bright yellow crystalline product (92% yield) was precipitated by n-hexane. The spectroscopic data of the product was in accordance with the reported literature. 2.1.4 Preparation of chiral complex E Then ethanolic solution of anhydrous CrCl2 (1.5 mmol, 15 mL) was slowly poured into the ethanolic solution of this Schiff base ligand (D) (1.0 mmol, 15 mL) under inert atmosphere and the solution was stirred for 2 h, which resulted the formation of bluish brown solution. Then the solution was exposed to air and stirring was sustained for another 15 h to obtain a dark brown solution. After completion of reaction the resulting brown solid was extracted by dichloromethane, washed with brine and finally dried by using anhydrous sodium sulphate. After evaporation of the solvent, the solid mass was precipitated out from n-hexane to get chiral Cr(III)-salen complex (E) as a dark brown solid (88% yield). TOF-MS of C42H68Cl3CrN4O2: m/z value was found 782.4038 for (M-Cl)+; [cal. 782.4124], FTIR spectroscopic data showed peaks of the complex at: 3385, 2959, 1651, 1592, 1532, 1437, 755 cm−1. 2.2 Preparation of -SO3H functionalized SBA-15 (SAFSB) The sulfonic acid functionalized SBA-15 support (designated as SAFSB) was synthesized following the literature reports [42,43]. Primarily, mesoporous solid support SBA-15 (F) has been synthesized hydrothermally and then 500 mg of it was suspended in dry toluene (15 mL). Then after addition of 5 mmol of 3-mercaptopropyltrimethoxysilane the ensuing mixture was refluxed for 24 h and filtered to obtain the solid mass. Next, in order to oxidise the immobilized 3-mercaptopropyl groups, 500 mg of the dried material was suspended in 5 g of aqueous 30 wt% H2O2 and then stirred at room temperature. After the completion of the reaction, the resulting solid mass was filtered out and washed using water and ethanol. Subsequently, the wet mass was suspended (1 wt%) in 1 M H2SO4 solution for 4 h. Finally, the material was washed several times with water and ethanol, and finally dried at 60 °C under vacuum overnight before carrying out the catalytic reactions. 2.3 Synthesis of the heterogeneous Cr(III)@SAFSB catalyst Ethanolic solution of homogeneous chiral Cr(III)-salen complex (E) (0.025 g, 5 mL) was added to the ethanolic suspension of mesoporous solid support SAFSB (0.25 g, 15 mL). The reaction mixture was allowed to stir at 308 K temperature for 12 h. The subsequent pale brown solid mass was centrifuged and extracted with methanol and dichloromethane using soxhlet apparatus till the washing become colourless. Finally, the catalyst designated as Cr(III)@SAFSB was dried under air. The entire synthetic pathway for the designing of chiral Cr(III)@SAFSB catalyst is presented in Scheme 2. 2.4 General procedure for asymmetric nitro aldol reaction A solution of freshly prepared chiral Cr(III)@SAFSB catalyst (15 mg, 0.249 mol% of Cr) in DCM (1.0 ml) was stirred at 4 °C for 15 min followed by the addition of aldehyde (1.0 mmol) and nitromethane (8.0 mmol) to it. After additional stirring for 30 min at the same temperature, 1.0 mmol of Et3N in DCM (1.0 ml) was added dropwise to the former solution and the final reaction mixture was stirred at 4 °C for a specific reaction time. The progress of reaction was monitored by thin layer chromatography (TLC) technique. After completion of the reaction solvent was evaporated by rotary evaporator and the solid sample was purified by column chromatography over silica gel with pet ether/ethyl acetate (85:15) as eluent. All the products were characterized using 1H NMR. The spectroscopic data are in full agreement with those previously reported compounds. Enantiomeric excess (ee) was determined by HPLC analysis using Chiralcel OD-H column. 2.5 Synthesis of (R)-(-)-Isoproterenol (R)-1-(3,4-dimethoxyphenyl)-2-nitroethanol (2 g) was prepared using 3,4-dimethoxy benzaldehyde (1 g) and CH3NO2 by following the optimized reaction conditions which is shown in Table 1 . Thereafter, the final drug molecule (R)-isoproterenol was prepared from (R)-1-(3,4-dimethoxyphenyl)-2-nitroethanol (2.0 g). The step-wise conversions were confirmed by 1H NMR, HPLC chromatograms and optical rotation values of the products (given in electronic supporting information), which are in full accordance with the reported values. 2.6 General procedure for recycling experiment After completion of the reaction, the crude reaction mixture was allowed to reach the room temperature and then extracted with ethyl acetate. Then the catalyst was separated through centrifugation and organic part was used to determine the product yield. Next, the separated catalyst was repeatedly washed with ethyl acetate and distilled water, and finally with DCM. Thereafter the catalyst was dried under vacuum and reused for the next run. 3 Results and discussion 3.1 Characterization of Cr(III)@SAFSB catalyst 3.1.1 Powder X-ray diffraction pattern (PXRD) The small angle PXRD pattern of SAFSB and Cr(III)@SAFSB materials are shown in Fig. 1 . Fig. 1a represents the small angle XRD pattern of SAFSB, where three characteristic diffraction peaks are observed at 2θ values of 0.88°, 1.54° and 1.76°, which could be ascribed to the three well-defined crystalline planes 100, 110 and 200, respectively for the two-dimensional ordered hexagonal mesophase of SBA-15 material [29]. Further, from Fig. 1b it is seen that similar noticeable peaks appear at 2θ values of 0.90°, 1.55° and 1.79° of 2θ for Cr(III)@SAFSB material due to the three distinctive crystal planes, suggesting the retention of 2D ordered hexagonally ordered mesophase after grafting of Cr-salen complex over the SAFSB surface. 3.1.2 UHR-TEM To determine the nanostructure of SAFSB and Cr(III)@SAFSB materials we have carried out ultra-high resolution transmission electron microscopy analysis. UHR-TEM images of SAFSB support are shown in Fig. 2 a and b. Microscopic view perpendicular to the pore axis suggested highly ordered arrangement of the mesopores. 2D ordered hexagonal pores with a diameter of ˜8.0 nm, are organized in a periodic fashion throughout the whole specimen [29,30]. The periodicity of hexagonally arranged pores are also quite clear after the loading of chiral Cr(III) complex in Cr(III)@SAFSB material (Fig. 2c,d). The Fast Fourier Transform (FFT) patterns of SAFSB and Cr(III)@SAFSB materials are shown in the inset of Fig. 2b and 2c respectively, suggesting the highly ordered hexagonal array of the pore channels in both the materials. 3.1.3 N2 adsorption/desorption isotherm Fig. 3 demonstrates the nitrogen adsorption-desorption isotherms of pure silica SBA-15 and Cr(III)@SAFSB materials. Both these isotherms could be classified as typical type IV isotherm along with large hysteresis loops of type H1 [30] in high relative pressure region, which suggested that the material contains uniform and large mesopores. The estimated BET (Brunauer-Emmett-Teller) surface area and pore volume of SBA-15 and Cr(III)@SAFSB materials were 765 and 407 m2 g−1, and 0.90 and 0.61 ccg−1, respectively. The pore size of the material has been estimated from these adsorption/desorption isotherms using NLDFT (Non-Local Density Functional Theory) method. Peak pore width for pure silica SBA-15 was 11.1 nm, which decreased to 8.0 nm (inset of Fig. 3) in Cr(III)@SAFSB. This result suggested that anchoring of chiral Cr(III) complex at the pore surface of SBA-15 reduces the pore width by 3.1 nm and this result agrees well with the UHR-TEM image analysis. 3.1.4 X-ray photoelectron spectroscopy (XPS) The high resolution XPS spectra of Cr(III)@SAFSB for different constituent elements are shown in Fig. 4 . As seen from the Fig. 4a two peaks corresponding to the spin-orbit splitting 2p1/2 (left) and 2p3/2 (right) of Cr 2p with two binding energy values of 587.4 and 576.9 eV, respectively confirmed the existence of Cr(III) in Cr(III)@SAFSB [44]. This result suggested the penta-coordinated Cr(III) with two charge balancing phenoxide ions and one chloride ion together with two coordination bonds with two imine-N atoms in Cr(III)@SAFSB (Scheme 2). In Fig. 4b one peak appeared at the binding energy value of 168.0 eV and this could be assigned due to the S2p component for the sulfonate groups present in the hybrid framework. This S2p spectrum of Cr(III)@SAFSB can be deconvoluted into two characteristic peaks at the binding energy values of 167.4 and 168.3 eV, which could be attributed to two components S2p1/2 and S2p3/2, respectively [45]. These characteristic peaks further suggest that the S is present mainly in form of -SO3H groups bonded to the carbon of the propyl group, which attached with Si atoms at the SBA-15 surface. The peak appears at the binding energy value of 284.8 eV for the C1 s component, shown in Fig. 4c, whereas that at 103.2 eV could be assigned due to the Si 2p (Fig. 4d). This result suggested the presence of silica and organic moieties in Cr(III)@SAFSB material. 3.1.5 FT-IR spectral analysis Figure S1 illustrates the FTIR spectra of SBA-15 (a), 3-MPTMS functionalized SBA-15 (b), sulfonic acid functionalized SBA-15 (c), homogeneous Cr(III) salen complex (d) and heterogeneous chiral Cr(III)@SAFSB catalyst (e). The successful synthesis of mesoporous SBA-15 material is confirmed by the appearance of the broad and instance peak near 3454 cm−1 (Si−OH bond) and 1079, 796 cm−1 (SiOSi bond) (a, Fig. S1). Next, the new peaks near about 2571 cm−1 (SH bond) and 762 cm−1 (−CH2-S) clearly indicate the formation of 3-MPTMS functionalized SBA-15 (b, Fig S1). Thereafter, the transformation of the -SH group to -SO3H group is assigned by the complete disappearance of the peak near 2571 cm−1 (SH bond) and appearance of the new band at 1154 cm−1 due to the symmetric and asymmetric stretching of the SO2 moieties [46] (c, Fig S1). In the IR spectrum of homogeneous Cr(III)-salen complex (d, Fig S1) the characteristic peaks near 1650-1400 cm−1 appear due to the presence of -CN groups’ stretching and the CH deformation stretching respectively. These peaks are also present in the heterogeneous Cr(III)@SAFSB catalyst (e, Fig S1). Hence the FTIR spectral study undoubtedly signify the step wise modification of SBA-15 and the efficacious synthesis of chiral Cr(III)@SAFSB catalyst. 3.1.6 Elemental analysis The carbon, hydrogen and nitrogen content in Cr(III)@SAFSB material are examined by CHN analysis, which suggested the elemental contents in the material as: C = 12.52 wt%, H = 2.57 wt% and N = 1.23 wt%. Using Varian AA240 atomic absorption spectrophotometer (AAS), the chromium content in the supported chiral catalyst was determined. The observed freshly prepared Cr(III)@SAFSB material showed the chromium content as 0.166 mmolg−1. Further, XPS analysis of Cr(III)@SAFSB suggested sulphur content of 14.19 atomic%. Calculated C/N, Cr/N and Cr/C ratios (based on proposed model in Scheme 2) were 10.31, 0.928 and 0.103, whereas those observed from chemical analysis of Cr(III)@SAFSB were 10.17, 0.700 and 0.069, respectively. This result agreed well considering the limit of experimental errors in chemical analysis. 3.2 Enantioselective Henry Reaction For establishing the optimized reaction conditions, a number of reactions have been performed using 4-methyl-benzaldehyde (1a) and nitro methane as the model substrates (Table 1). We are delighted to inform that, without any catalyst, solvent and base no product was formed (Entry 1, Table 1). Among various solvents, ethanol, diethyl ether, tetrahydrofuran, toluene, etc. were used for this reaction, where DCM provides the unbeatable upshots in case of yield as well as ee of the product 2a (Entry 2–6, Table 1). The reaction provides only 55% yield and 78% ee of the product yield without using any base (Entry 7, Table 1). In contrast, both yield and ee values are increased dramatically with increasing amount of base. To optimize the suitable base for this reaction, diisopropyl ethylamine (DIPEA), Et3N, Cs2CO3, 1,8-diazabicyclo-[5.4.0]-undec-7-ene (DBU) were used but 1.0 mmol of Et3N showed the best product (Entry 8–10, Table 1). The temperature required for the reaction was also optimized. Lowering the temperature from 4 to -10 °C, results an enhancement in reaction selectivity along with a decreased value of product yield, while reaction at room temperature severely loses both activity and selectivity (Entry 11–12, Table 1). Next, amount of the chiral catalyst required for the reaction, was screened and was found that only 15 mg (0.249 mol% of Cr) Cr(III)@SAFSB catalyst shows the best results (Entry 13–14, Table 1). The catalytic activity of SBA-15 and sulfonic acid functionalized material SAFSB were also examined and it was found that in the both of these cases, very low amounts of the products are formed (10 and 12%, respectively) (Entry 16–17, Table 1). Moreover, reaction using equimolar amount of nitromethane produces the corresponding product (2a), but only with 39% yield and 83% ee (Entry 18, Table 1) Thus, our optimized reaction condition provide the best result in terms of the yield and ee of the product using Et3N as a base, 15 mg (0.249 mol% of Cr) of Cr(III)@SAFSB catalyst at 4 °C temperature in DCM for 16 h (Entry 6, Table 1). After achieving the optimum reaction condition, we further extended our work for the synthesis of a bunch of β-hydroxy nitroalkanes using various substituted aromatic aldehydes and nitromethane (Table 2 ). We are glee to report that, aromatic aldehydes, substituted with both electron donating as well as withdrawing groups in diverse substitution position of the phenyl ring, furnish the corresponding products in moderate to good yields (up to 90%) and ee (up to 91%). Parallelly, we have employed our catalyst to the asymmetric Henry reaction using thiophene-2-carbaldehyde and furan-2-carbaldehyde (Entry 8, 9, Table 2) as the aldehyde partner. Interestingly, the reaction furnishes (S)-1-(thiophen-2-yl)-2-nitroethanol and (S)-1-(furan-2-yl)-2-nitroethanol as the final product with 80–82% yield and 83–86% ee. In addition, with these aromatic and heteroaromatic aldehydes we further extended our endeavour for the same reaction using heptanal as an aliphatic aldehyde partner. Here we acquired the desired product with 78% yield and 77% ee (Entry 10, Table 2). The whole catalytic performances using Cr(III)@SAFSB chiral catalyst with (S, S) configuration provide the corresponding β-hydroxy nitroalkanes with R-configurations. Only the exceptions are thiophene-2-carbaldehyde and furan-2-carbaldehyde due to the formal reason of the CIP notation. Consequently, our results are in coherence with the results obtained using chiral thiophene-salen chromium complexes by Zulauf et al. [27] as well as podand-based dimeric Cr(III)-salen complex by Ouyang et al. [28]. A plausible mechanism is shown in Scheme 3 based on the product’s configuration. Since the Si-face attack is hindered by the steric factor, the nucleophilic attack could take place only from Re-face giving the R enantiomer exclusively. The synthesis of the products has been inspected by 1H-NMR spectroscopic analysis and the corresponding ee values were estimated through HPLC analyses by the use of Chiralcel OD-H column (ESI†). Finally, our current catalytic system, was successfully applied for the preparation of medicinally demanding drug (R)-isoproterenol (Section I, ESI) [47]. The total synthetic path of (R)-isoproterenol drug is outlined in Scheme 4 , which revealed that chiral Cr(III)@SAFSB catalyzed asymmetric nitro aldol reaction of 3,4-dimethoxybenzaldehyde with nitromethane has employed as the crucial step for this preparation (Section II, ESI). The efficiency of our newly generated heterogeneous Cr(III)@SAFSB catalyst was compared with the non-immobilized Cr(III)-salen complex (E) for the representative reaction between benzaldehyde (1b) and nitromethane under optimized reaction conditions and the result are summarized in Table 3 . From this result it is clear that the activity of our heterogeneous chiral Cr(III)@SAFSB catalyst is quite similar to that of its homogeneous non-immobilized counterpart (HPLC chromatograms are given in Fig S3-S4, ESI). 3.3 Reusability of chiral Cr(III)@SAFSB catalyst Recyclability is one of the foremost valuable characteristics of a heterogeneous catalyst. To study the recyclability of our catalyst, we have performed asymmetric Henry reaction using benzaldehyde and nitromethane as the model substrate and it was found that, our newly synthesized chiral catalyst can be recycled for 6 repeated runs without considerable loss in its activity and selectivity (Fig. 5 ). This fact was confirmed through the FTIR spectral analysis of recycled catalyst (after sixth run). FTIR spectra of the reused catalyst (Fig. S2) contains the necessary peaks that correspond to the functional groups present in the material. This fact clearly represents that the functional groups in the material remain nearly unaltered after reuse. 3.4 Leaching tests To examine the possibilities of metal leaching, a solution of freshly prepared chiral Cr(III)@SAFSB catalyst (15 mg, 0.249 mol% of Cr) in DCM (1.0 ml) was stirred at 4 °C for 15 min followed by the addition of aldehyde (1.0 mmol) and nitromethane (8.0 mmol) to it. After additional stirring for 30 min at the same temperature, 1.0 mmol of Et3N in DCM (1.0 ml) was added dropwise to the former solution and the final reaction mixture was subjected for stirring at 4 °C for 8 h. Then the catalyst was filtered out from the reaction medium at that temperature and only 42% yield of the product was obtained by GC analysis. Thereafter, the filtrate was further stirred for another 8 h at 4 °C. Finally, after 16 h yield of the product was determined by GC and it was found that no considerable conversion was taking place after separation of the catalyst. This result clearly indicates that, the reaction did not progress in absence of the catalyst. Further, AAS measurement was performed using the final reaction mixture and leached metal ion (Cr(III)) could not be detected in the filtrate or its content was below the detection limit of the instrument (0.003 mg/L). Successful immobilization of the chiral metal complexes over porous solid supports is very challenging area especially in heterogeneous catalysis [48]. Thus, the catalytic activity and enantioselectivity of chiral Cr(III)@SAFSB catalyst was compared with the literature reports on diverse range of homogeneous and heterogeneous chiral catalysts. Table S1 summarizes the results, which revealed that this supported chiral Cr catalyst offers comparatively better activity in terms of product yield, enantiomeric excess and turn over numbers (TONs). 4 Conclusion A new heterogeneous chiral catalyst has been prepared through the post-synthesis grafting of chiral Cr(III)-salen complex onto the sulfonic acid functionalized mesoporous SBA-15 material. The catalyst revealed good catalytic activity in enantioselective nitroaldol reaction to provide a bunch of β-hydroxy nitroalkanes with moderate to good yield and enantioselectivity. Diversely substituted aromatic aldehydes reacted smoothly to furnish their corresponding products. Moreover, heterocyclic as well as aliphatic aldehydes also undergo this reaction providing the respective products with good yield and ee. In addition, using this reaction conditions as one of the key steps, chiral pure drug (R)-isoproterenol has also been synthesized. Functionalized mesoporous chiral catalyst reported herein offers very high surface area and uniform distribution of active sites throughout the material, overall time required for the reaction is comparatively low, wide variety of substrates undergo the reaction under same reaction conditions, high yield and enantioselectivity of the synthesized products, no need of any additives, high turnover numbers and good recycling efficiency. Thus, the present work may open-up enormous prospect in asymmetric catalysis based on surface modified mesoporous materials in future. Acknowledgments SMI thankfully acknowledges Council of Scientific and Industrial and Research, CSIR (project reference no 02(0284)2016/EMR-II dated 06/12/2016) New Delhi, Govt. of India and Department of Science and Technology, DST-SERB (project reference no. EMR/2016/004956), New Delhi, Govt. of India and Board of Research in Nuclear Sciences (BRNS), Project reference No: 37(2)/14/03/2018-BRNS/37003, Govt. of India for providing financial support. MMI and MH acknowledge UGC for providing UGC-MANF-SRF and UGC-SRF, respectively. PB acknowledges CSIR, New Delhi for providing CSIR-SRF. We sincerely acknowledge the DST and UGC, New Delhi, Govt. of India, for providing grant under FIST, PURSE and SAP program to the Department of Chemistry, University of Kalyani. AB acknowledges DST-SERB, New Delhi for an extramural project grant. Appendix A Supplementary data Supplementary material related to this article can be found, in the online version, at doi:https://doi.org/10.1016/j.mcat.2019.110489. Appendix A Supplementary data The following is Supplementary data to this article: References [1] C. Palomo M. Oiarbide A. Laso Eur. J. Org. Chem. 2007 2007 2561 2574 C. Palomo, M. Oiarbide, A. Laso, Eur. J. Org. Chem. 2007 (2007) 2561-2574. [2] T. Menapara M.K. Choudhary R. Tak R.I. Kureshy N.H. Khan S.H.R. Abdi J. Mol. Catal. A Chem. 421 2016 161 166 T. Menapara, M. K. Choudhary, R. Tak, R. I. Kureshy, N. H. Khan, S. H. R. Abdi, J. Mol. Catal. A: Chem. 421 (2016) 161-166. [3] M. Bandini F. Piccinelli S. Tommasi A. Umani-Ronchi C. Ventrici Chem. Commun. (Camb.) 2007 616 618 M. Bandini, F. Piccinelli, S. Tommasi, A. Umani-Ronchi, C. Ventrici, Chem. Commun. (2007) 616-618. [4] B.M. Trost V.S.C. Yeh H. Ito N. Bremeyer Org. Lett. 4 2002 2621 2623 B. M. Trost, V. S. C. Yeh, H. Ito, N. Bremeyer, Org. Lett. 4 (2002) 2621-2623. [5] Z. Ma A.V. Gurbanov A.M. Maharramov F.I. Guseinov M.N. Kopylovich F.I. Zubkov K.T. Mahmudov A.J.L. Pombeiro J. Mol. Catal. A Chem. 426 2017 526 533 Z. Ma, A. V. Gurbanov, A. M. Maharramov, F. I. Guseinov, M. N. Kopylovich, F. I. Zubkov, K. T. Mahmudov, A. J. L. Pombeiro, J. Mol. Catal. A: Chem. 426 (2017) 526-533. [6] K. Lang J. Park S. Hong Angew. Chem. Int. Ed. 51 2012 1620 1624 K. Lang, J. Park, S. Hong, Angew. Chem. Int. Ed. 51 (2012) 1620-1624. [7] K.K. Sharma A.V. Biradar T. Asefa ChemCatChem 2 2010 61 66 K. K. Sharma, A. V. Biradar, T. Asefa, ChemCatChem 2 (2010) 61-66. [8] B. El-Asaad E. Metay I. Karame M. Lemaire Mol. Catal. 435 2017 76 81 B. El-Asaad, E. Metay, I. Karame, M. Lemaire, Mol. Catal. 435 (2017) 76-81. [9] F. Wang X.H. Liu X. Cui Y. Xiong X. Zhou X.M. Feng Chem. Eur. J. 15 2009 589 592 F. Wang, X. H. Liu, X. Cui, Y. Xiong, X. Zhou, X. M. Feng, Chem. Eur. J. 15 (2009) 589-592. [10] N. Mase K. Watanabe H. Yoda K. Takabe F. Tanaka C.F. Barbas III J. Am. Chem. Soc. 128 2006 4966 4967 N. Mase, K. Watanabe, H. Yoda, K. Takabe, F. Tanaka, C. F. Barbas III, J. Am. Chem. Soc. 128 (2006) 4966-4967. [11] S. Jalal S. Sarkar K. Bera S. Maiti U. Jana Eur. J. Org. Chem. 2013 2013 4823 4830 S. Jalal, S. Sarkar, K. Bera, S. Maiti, U. Jana, Eur. J. Org. Chem. 2013 (2013) 4823-4830. [12] H. Sasai T. Suzuki T. Arai M. Shibasaki J. Am. Chem. Soc. 114 1992 4418 4420 H. Sasai, T. Suzuki, T. Arai, M. Shibasaki, J. Am. Chem. Soc. 114 (1992) 4418-4420. [13] L.S. Aitken N.R. Arezki A. Dell’Isola A.J.A. Cobb Synthesis 45 2013 2627 2648 L. S. Aitken, N. R. Arezki, A. Dell’Isola, A. J. A. Cobb, Synthesis 45 (2013) 2627-2648. [14] X. Liu C. Manzur N. Novoa S. Celedón D. Carrillo J.-R. Hamon Coord. Chem. Rev. 357 2018 144 172 X. Liu, C. Manzur, N. Novoa, S. Celedón, D. Carrillo, J.-R. Hamon, Coord. Chem. Rev. 357 (2018) 144-172. [15] R.I. Kureshy A. Das N.H. Khan S.H.R. Abdi H.C. Bajaj ACS Catal. 1 2011 1529 1535 R. I. Kureshy, A. Das, N. H. Khan, S. H. R. Abdi, H. C. Bajaj, ACS Catal. 1 (2011) 1529-1535. [16] S. Jammi M.A. Ali S. Sakthivel L. Rout T. Punniyamurthy Chem. Asian J. 4 2009 314 320 S. Jammi, M. A. Ali, S. Sakthivel, L. Rout, T. Punniyamurthy, Chem. Asian J. 4 (2009) 314-320. [17] A. Das R.I. Kureshy P.S. Subramanian N.H. Khan S.H.R. Abdi H.C. Bajaj Catal. Sci. Technol. 4 2014 411 418 A. Das, R. I. Kureshy, P. S. Subramanian, N. H. Khan, S. H. R. Abdi, H. C. Bajaj, Catal. Sci. Technol. 4 (2014) 411-418. [18] Y. Alvarez-Casao E. Marques-Lopez R.P. Herrera Symmetry 3 2011 220 245 Y. Alvarez-Casao, E. Marques-Lopez, R. P. Herrera, Symmetry 3 (2011) 220-245. [19] T. Sekikawa T. Kitaguchi H. Kitaura T. Minami Y. Hatanaka Org. Lett. 18 2016 646 649 T. Sekikawa, T. Kitaguchi, H. Kitaura, T. Minami, Y. Hatanaka, Org. Lett. 18 (2016) 646-649. [20] A. Bulut A. Aslan O. Dogan J. Org. Chem. 73 2008 7373 7375 A. Bulut, A. Aslan, O. Dogan, J. Org. Chem. 73 (2008) 7373-7375. [21] M. Shibasaki H. Sasai T. Arai Angew. Chem. Int. Ed. Engl. 36 1997 1236 1256 M. Shibasaki, H. Sasai, T. Arai, Angew. Chem., Int. Ed. Engl. 36 (1997) 1236-1256. [22] J. Park K. Lang K.A. Abboud S. Hong J. Am. Chem. Soc. 130 2008 16484 16485 J. Park, K. Lang, K.A. Abboud, S. Hong, J. Am. Chem. Soc. 130 (2008) 16484-16485. [23] J. Dimroth M. Weck RSC Adv. 5 2015 29108 29113 J. Dimroth, M. Weck, RSC Adv. 5 (2015) 29108-29113. [24] S.U. Pandya R.S. Dickins D. Parker Org. Biomol. Chem. 5 2007 3842 3846 S. U. Pandya, R. S. Dickins, D. Parker, Org. Biomol. Chem. 5 (2007) 3842-3846. [25] A.P. Bhatt K. Pathak R.V. Jasra R.I. Kureshy N.H. Khan S.H.R. Abdi J. Mol. Catal. A Chem. 244 2006 110 117 A. P. Bhatt, K. Pathak, R.V. Jasra, R. I. Kureshy, N. H. Khan, S. H. R. Abdi, J. Mol. Catal. A: Chem. 244 (2006) 110-117. [26] R. Kowalczyk P. Kwiatkowski J. Skarzewski J. Jurczak J. Org. Chem. 74 2009 753 756 R. Kowalczyk, P. Kwiatkowski, J. Skarzewski, J. Jurczak, J. Org. Chem. 74 (2009) 753-756. [27] A. Zulauf M. Mellah E. Schulz J. Org. Chem. 74 2009 2242 2245 A. Zulauf, M. Mellah, E. Schulz, J. Org. Chem. 74 (2009) 2242-2245. [28] G.-H. Ouyang Y.-M. He Q.-H. Fan Chem. Eur. J. 20 2014 16454 16457 G.-H. Ouyang, Y.-M. He, Q.-H. Fan, Chem. Eur. J. 20 (2014) 16454-16457. [29] D.Y. Zhao J.L. Feng Q.S. Huo N. Melosh G.H. Fredrickson B.F. Chmelka G.D. Stucky Science 279 1998 548 552 D. Y. Zhao, J. L. Feng, Q. S. Huo, N. Melosh, G. H. Fredrickson, B. F. Chmelka, G. D. Stucky, Science 279 (1998) 548-552. [30] S.K. Das M.K. Bhunia A. Bhaumik J. Solid State Chem. 183 2010 1326 1333 S. K. Das, M. K. Bhunia, A. Bhaumik, J. Solid State Chem. 183 (2010) 1326-1333. [31] S. Verma M. Nandi A. Modak S.L. Jain A. Bhaumik Adv. Synth. Catal. 353 2011 1897 1902 S. Verma, M. Nandi, A. Modak, S. L. Jain, A. Bhaumik, Adv. Synth. Catal. 353 (2011) 1897-1902. [32] S.Y. Chen T. Yokoi C.Y. Tang L.Y. Jang T. Tatsumi J.C.C. Chan S.F. Cheng Green Chem. 13 2011 2920 2930 S. Y. Chen, T. Yokoi, C. Y. Tang, L. Y. Jang, T. Tatsumi, J. C. C. Chan, S. F. Cheng, Green Chem. 13 (2011) 2920-2930. [33] K. Ponnuru J.C. Manayil H.J. Cho A. Osatiashtiani W. Fan K. Wilson F.C. Jentoft Mol. Catal. 458 2018 247 260 K. Ponnuru, J. C. Manayil, H. J. Cho, A. Osatiashtiani, W. Fan, K. Wilson, F. C. Jentoft, Mol. Catal. 458 (2018) 247-260. [34] M.M. Islam P. Bhanja M. Halder S.K. Kundu A. Bhaumik S.M. Islam RSC Adv. 6 2016 109315 109321 M. M. Islam, P. Bhanja, M. Halder, S. K. Kundu, A. Bhaumik, S. M. Islam, RSC Adv. 6 (2016) 109315-109321. [35] S. Ostovar A. Franco A.R. Puente-Santiago M. Pinilla-de Dios D. Rodriguez-Padron H.R. Shaterian R. Luque Front. Chem. 6 2018 77 S. Ostovar, A. Franco, A. R. Puente-Santiago, M. Pinilla-de Dios, D. Rodriguez-Padron, H. R. Shaterian, R. Luque, Front. Chem. 6 (2018) 77. [36] F. Liguori P. Barbaro B. Said A. Galarneau V.D. Santo E. Passaglia A. Feis ChemCatChem 9 2017 3245 3258 F. Liguori, P. Barbaro, B. Said, A. Galarneau, V. D. Santo, E. Passaglia, A. Feis, ChemCatChem 9 (2017) 3245-3258. [37] M. Halder P. Bhanja S. Roy S. Ghosh S. Kundu M.M. Islam S.M. Islam RSC Adv. 6 2016 97599 97605 M. Halder, P. Bhanja, S. Roy, S. Ghosh, S. Kundu, M. M. Islam, S. M. Islam, RSC Adv. 6 (2016) 97599-97605. [38] M. Halder P. Bhanja M.M. Islam A. Bhaumik S.M. Islam New J. Chem. 42 2018 11896 11904 M. Halder, P. Bhanja, M. M. Islam, A. Bhaumik, S. M. Islam, New J. Chem. 42 (2018) 11896-11904. [39] N. Regamey M. Ochs T.N. Hilliard C. Muehlfeld N. Cornish L. Fleming S. Saglani E.W.F.W. Alton A. Bush P.K. Jeffery J.C. Davies Am. J. Resp. Critical Care Med. 177 2008 837 843 N. Regamey, M. Ochs, T. N. Hilliard, C. Muehlfeld, N. Cornish, L. Fleming, S. Saglani, E. W. F. W. Alton, A. Bush, P. K. Jeffery, J. C. Davies, Am. J. Resp. Critical Care Med. 177 (2008) 837-843. [40] Y. Konishi, J. Magoon, A. Mullick, Int. Patent WO 2007109882, A1 20071004, 2007. [41] R. Vilskersts E. Liepinsh J. Kuka H. Cirule M. Veveris I. Kalvinsh M. Dambrova Cardiovasc. Drug Ther. 23 2009 281 R. Vilskersts, E. Liepinsh, J. Kuka, H. Cirule, M. Veveris, I. Kalvinsh, M. Dambrova, Cardiovasc. Drug Ther. 2009, 23, 281 [42] M. Sasidharana A. Bhaumik J. Mol. Catal. A Chem. 367 2013 1 6 M. Sasidharana, A. Bhaumik, J. Mol. Catal. A: Chem. 367 (2013) 1-6. [43] F. Adam M.S. Batagarawa K.M. Hello S.S. Al-Juaid Chem. Pap. 66 2012 1048 1058 F. Adam, M. S. Batagarawa, K. M. Hello, S. S. Al-Juaid, Chemical Papers 66 (2012) 1048-1058. [44] X. Li R. Zhao B. Sun X. Lu C. Zhang Z. Wang C. Wang RSC Adv. 4 2014 42376 42382 X. Li, R. Zhao, B. Sun, X. Lu, C. Zhang, Z. Wang, C. Wang, RSC Adv. 4 (2014) 42376-42382. [45] K. Nakajima M. Hara ACS Catal. 2 2012 1296 K. Nakajima, M. Hara, ACS Catal. 2 (2012) 1296. [46] A. Das R.I. Kureshy K.J. Prathap M.K. Choudhary G.V.S. Rao N.H. Khan S.H.R. Abdi H.C. Bajaj Appl. Catal. A Gen. 459 2013 97 105 A. Das, R. I. Kureshy, K. J. Prathap, M. K. Choudhary, G. V. S. Rao, N. H. Khan, S. H. R. Abdi, H. C. Bajaj, Appl. Catal. A: Gen. 459 (2013) 97-105. [47] G. Blay V. Hernandez-Olmos J.R. Pedro Tetrahedron Asymmetry 21 2010 578 581 G. Blay, V. Hernandez-Olmos, J. R. Pedro, Tetrahedron: Asymmetry, 21 (2010) 578-581. [48] B. Pugin H.Ulrich Blaser P. Barbaro F. Liguori Heterogenized Homogeneous Catalysts for Fine Chemicals Production 2010 Springer London Chapter 7 B. Pugin and H.-Ulrich Blaser in Heterogenized Homogeneous Catalysts for Fine Chemicals Production, Ed. P. Barbaro and F. Liguori, Springer, London, 2010, Chapter 7.",
      "scopus-id": "85067915877",
      "coredata": {
        "eid": "1-s2.0-S2468823119303244",
        "dc:description": "Designing novel catalytic system for efficient synthesis of enantiomerically pure β-hydroxy nitroalkanes is a challenging area of research. Herein, we have designed a chiral heterogeneous catalyst through the successful loading of chiral Cr(III)-salen complex over sulfonic acid functionalized SBA-15 material. The catalyst has been thoroughly characterized by powder XRD, N2 adsorption/desorption, XPS, HR-TEM, CHN, AAS analyses and FT-IR spectroscopy. The reactivity of the catalyst has been examined in the enantioselective Henry reaction, where different substituted aromatic, heteroaromatic as well as aliphatic aldehydes produced corresponding β-hydroxy nitroalkanes with excellent product yields (up to 90%) and enantioselectivities (up to 91%). Moreover, this protocol has also been employed as the key-step to prepare enantiomerically pure drug (R)-(-)-isoproterenol from 3,4-dimethoxybenzaldehyde.",
        "openArchiveArticle": "false",
        "prism:coverDate": "2019-10-31",
        "openaccessUserLicense": null,
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/article/pii/S2468823119303244",
        "dc:creator": [
          {
            "@_fa": "true",
            "$": "Islam, Md. Mominul"
          },
          {
            "@_fa": "true",
            "$": "Bhanja, Piyali"
          },
          {
            "@_fa": "true",
            "$": "Halder, Mita"
          },
          {
            "@_fa": "true",
            "$": "Das, Anjan"
          },
          {
            "@_fa": "true",
            "$": "Bhaumik, Asim"
          },
          {
            "@_fa": "true",
            "$": "Islam, Sk. Manirul"
          }
        ],
        "link": [
          {
            "@_fa": "true",
            "@rel": "self",
            "@href": "https://api.elsevier.com/content/article/pii/S2468823119303244"
          },
          {
            "@_fa": "true",
            "@rel": "scidir",
            "@href": "https://www.sciencedirect.com/science/article/pii/S2468823119303244"
          }
        ],
        "dc:format": "application/json",
        "openaccessType": null,
        "pii": "S2468-8231(19)30324-4",
        "prism:volume": "475",
        "articleNumber": "110489",
        "prism:publisher": "Elsevier B.V.",
        "dc:title": "Chiral Cr(III)-salen complex embedded over sulfonic acid functionalized mesoporous SBA-15 material as an efficient catalyst for the asymmetric Henry reaction",
        "prism:copyright": "© 2019 Elsevier B.V. All rights reserved.",
        "openaccess": "0",
        "prism:issn": "24688231",
        "dcterms:subject": [
          {
            "@_fa": "true",
            "$": "Asymmetric synthesis"
          },
          {
            "@_fa": "true",
            "$": "Nitroaldol reaction"
          },
          {
            "@_fa": "true",
            "$": "Heterogeneous catalysis"
          },
          {
            "@_fa": "true",
            "$": "Cr(III)-salen"
          },
          {
            "@_fa": "true",
            "$": "(R)-isopoterenol"
          }
        ],
        "openaccessArticle": "false",
        "prism:publicationName": "Molecular Catalysis",
        "openaccessSponsorType": null,
        "prism:pageRange": "110489",
        "pubType": "fla",
        "prism:coverDisplayDate": "October 2019",
        "prism:doi": "10.1016/j.mcat.2019.110489",
        "prism:startingPage": "110489",
        "dc:identifier": "doi:10.1016/j.mcat.2019.110489",
        "openaccessSponsorName": null
      },
      "objects": {
        "object": [
          {
            "@category": "thumbnail",
            "@height": "40",
            "@width": "219",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-fx1.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "2903",
            "@ref": "fx1",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "32",
            "@width": "219",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-fx2.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "3053",
            "@ref": "fx2",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "111",
            "@width": "219",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-ga1.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "9588",
            "@ref": "ga1",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "164",
            "@width": "144",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr1.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "3931",
            "@ref": "gr1",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "163",
            "@width": "164",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr2.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "15772",
            "@ref": "gr2",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "163",
            "@width": "99",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr3.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "5170",
            "@ref": "gr3",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "164",
            "@width": "164",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr4.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "7461",
            "@ref": "gr4",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "103",
            "@width": "219",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr5.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "8504",
            "@ref": "gr5",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "52",
            "@width": "219",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-sc1.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "3335",
            "@ref": "sc1",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "164",
            "@width": "139",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-sc2.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "7333",
            "@ref": "sc2",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "116",
            "@width": "219",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-sc3.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "5907",
            "@ref": "sc3",
            "@mimetype": "image/gif"
          },
          {
            "@category": "thumbnail",
            "@height": "147",
            "@width": "219",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-sc4.sml?httpAccept=%2A%2F%2A",
            "@multimediatype": "GIF image file",
            "@type": "IMAGE-THUMBNAIL",
            "@size": "8315",
            "@ref": "sc4",
            "@mimetype": "image/gif"
          },
          {
            "@category": "standard",
            "@height": "47",
            "@width": "257",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-fx1.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "4882",
            "@ref": "fx1",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "37",
            "@width": "247",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-fx2.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "5189",
            "@ref": "fx2",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "200",
            "@width": "396",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-ga1.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "26017",
            "@ref": "ga1",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "385",
            "@width": "339",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr1.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "20528",
            "@ref": "gr1",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "563",
            "@width": "565",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr2.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "104221",
            "@ref": "gr2",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "557",
            "@width": "339",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr3.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "43591",
            "@ref": "gr3",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "564",
            "@width": "565",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr4.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "61705",
            "@ref": "gr4",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "160",
            "@width": "339",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-gr5.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "17203",
            "@ref": "gr5",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "81",
            "@width": "339",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-sc1.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "9564",
            "@ref": "sc1",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "667",
            "@width": "565",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-sc2.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "93917",
            "@ref": "sc2",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "259",
            "@width": "489",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-sc3.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "25181",
            "@ref": "sc3",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@height": "328",
            "@width": "489",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-sc4.jpg?httpAccept=%2A%2F%2A",
            "@multimediatype": "JPEG image file",
            "@type": "IMAGE-DOWNSAMPLED",
            "@size": "39640",
            "@ref": "sc4",
            "@mimetype": "image/jpeg"
          },
          {
            "@category": "standard",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-mmc1.doc?httpAccept=%2A%2F%2A",
            "@multimediatype": "Microsoft Word file",
            "@type": "APPLICATION",
            "@size": "1239040",
            "@ref": "mmc1",
            "@mimetype": "application/word"
          },
          {
            "@category": "standard",
            "@_fa": "true",
            "$": "https://api.elsevier.com/content/object/eid/1-s2.0-S2468823119303244-am.pdf?httpAccept=%2A%2F%2A",
            "@multimediatype": "Acrobat PDF file",
            "@type": "AAM-PDF",
            "@size": "794707",
            "@ref": "am",
            "@mimetype": "application/pdf"
          }
        ]
      },
      "link": {
        "@rel": "abstract",
        "@href": "https://api.elsevier.com/content/abstract/scopus_id/85067915877"
      }
    }
  }
}